Shanghai MicroPort MedBot (Group) Co., Ltd. Class H's market cap is currently HK$20.33B. The company's EPS TTM is HK$-0.846; its P/E ratio is ―; Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 104.59M	¥ 21.60M	¥ 2.15M	¥ 0.00	¥ 0.00
Gross Profit	¥ 14.69M	¥ 6.56M	¥ 919.00K	¥ 0.00	¥ 0.00
Operating Income	¥ -975.14M	¥ -1.10B	¥ -610.18M	¥ -158.43M	¥ -69.27M
EBITDA	¥ -893.36M	¥ -1.01B	¥ -543.84M	¥ -160.93M	¥ -69.22M
Net Income	¥ -1.01B	¥ -1.17B	¥ -542.69M	¥ -261.25M	¥ -70.32M
Balance Sheet
Cash & Short-Term Investments	¥ 507.71M	¥ 747.96M	¥ 1.94B	¥ 1.50B	¥ 54.71M
Total Assets	¥ 1.43B	¥ 1.93B	¥ 2.79B	¥ 1.70B	¥ 78.44M
Total Debt	¥ 560.42M	¥ 219.95M	¥ 204.68M	¥ 18.88M	¥ 11.92M
Net Debt	¥ 52.71M	¥ -528.01M	¥ -1.74B	¥ -1.48B	¥ -42.79M
Total Liabilities	¥ 926.15M	¥ 522.25M	¥ 401.73M	¥ 262.90M	¥ 52.02M
Stockholders' Equity	¥ 519.48M	¥ 1.42B	¥ 2.39B	¥ 1.44B	¥ 26.41M
Cash Flow
Free Cash Flow	¥ -634.30M	¥ -1.09B	¥ -674.47M	¥ -118.05M	¥ -52.37M
Operating Cash Flow	¥ -567.84M	¥ -898.48M	¥ -540.49M	¥ -103.04M	¥ -48.70M
Investing Cash Flow	¥ -58.38M	¥ -267.82M	¥ -396.57M	¥ -15.01M	¥ 26.72M
Financing Cash Flow	¥ 385.68M	¥ -27.95M	¥ 1.39B	¥ 1.56B	¥ 71.28M

Currency in CNY

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Debt to Assets

Balance Sheet >

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Cash Flow

Cash Flow >

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing